Sigletic

Sigletic is a medication containing sitagliptin, used to manage type 2 diabetes. This oral medication helps control blood sugar levels and is manufactured by Zaklady Farmaceutyczne Polpharma S.A.

Sigletic is primarily used to manage type 2 diabetes by helping to control blood sugar levels. It works by increasing the levels of insulin released by the pancreas and decreasing the amount of sugar made by the liver. This medication is often used as part of a comprehensive treatment plan that includes diet and exercise.

Common effects of Sigletic may include headaches, nausea, and diarrhea. Some users might also experience upper respiratory infections or joint pain. These effects vary among individuals and are not experienced by everyone who takes the medication.

Sigletic should be handled with care, especially by individuals with a history of kidney problems or pancreatitis. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication as directed to maintain its effectiveness.

Sigletic may interact with other medications, including insulin and certain antibiotics. It is advisable to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.